Safety and efficacy of the addition of bevacizumab (BV) to temozolomide (TMZ) and radiation therapy (RT) followed by BV, TMZ, and irinotecan (CPT-11) for newly diagnosed glioblastoma multiforme (GBM)

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Vredenburgh, JJ; Desjardins, A; Reardon, DA; Peters, K; Herndon, JE; Kirkpatrick, J; Gururangan, S; Bailey, L; Friedman, AH; Friedman, HS

Published Date

  • May 20, 2009

Published In

Volume / Issue

  • 27 / 15

Published By

Pages

  • 2

International Standard Serial Number (ISSN)

  • 0732-183X

Conference Name

  • 45th Annual Meeting of the American-Society-of-Clinical-Oncology

Conference Location

  • Orlando, FL

Conference Start Date

  • May 29, 2009

Conference End Date

  • June 2, 2009